Governor gets 4 bills that would crack down on addiction treatment scams, raise standards

Governor gets 4 bills that would crack down on addiction treatment scams, raise standards Link to article about these bills that appeared on 9/18/2019 in the Orange County Register CSAM’s co-sponsored bill, AB-920 (Petrie-Norris), is on the Governor’s desk to sign. This bill would require outpatient centers, which are now unsupervised by the state, to be licensed, regulated, and to adopt treatment criteria set by ASAM as the minimum standard of care. Also on the Governor’s desk:

AB-919 (Petrie-Norris) – would crack down on financial conflicts-of-interest among rehab operators

SB-589 (Bates) – would prohibit rehabs and sober homes from making false or misleading advertising statements

AB-290 (Wood) – would remove the financial incentive for treatment providers to lure people to California by promising “free” insurance coverage

Make your voice heard. By contacting the Governor using the link below, you can send your own comments about any of these bills:

https://govapps.gov.ca.gov/gov40mail/ (Use the pull down menu to click on the bill number to create a subject line for your message)

CSAM Newsletter Spring 2019 issue

CSAM News Spring 2019

  • President’s Message – Follow the Evidence
  • The Death Certificate Project | CSAM President’s Testimony at the Medical Board of CA
  • CSAM Leadership Development Retreat
  • CSAM Addiction Medicine Review Course and Board Exam Preparation Track 2019
  • Funding Provides Scholarships for Mentored Learning Experiences at CSAM Addiction Medicine Review Course
  • Call for CSAM Board of Directors Nominations
  • CA Bridge Program Offers Training and Assistance
  • The CA Department of Public Health’s All Facilities Letter (AFL)

New MAT Webinars on CSAM Education Center!

Please visit the CSAM Education center to watch the new MAT webinars: Real Cases of Buprenorphine-Naloxone Treatment: What to do and how to do it? featuring CSAM members, Soraya Azari, MD, Kenneth Saffier, MD, FASAM and Scott Steiger, MD, FACP, FASAM.

Transdermal Buprenorphine for Induction of Patients with Co-Morbid Pain featuring CSAM members, Soraya Azari, MD and Tauheed Zaman, MD. These webinars are FREE for CSAM members.

These are two 2019 webinars on Medication Assisted Treatment (MAT) in primary care settings created by the California Society of Addiction Medicine (CSAM) with the support of a grant from the California Department of Healthcare Services (DHCS). 

We hope you enjoy the webinar!
CSAM Education Team

Recommendations for Safe Opioid Prescribing

CSAM Recommendations for Safe Opioid Prescribing

Version 1.0 (03/01/19)

Important Notes:

  • These recommendations were initially developed by Kaiser Permanente and then modified and endorsed by Safe Med LA and on December 12, 2018 by the California Society of Addiction Medicine’s (CSAM) Committee on Opioids. They are based on recommendations and guidelines from the Centers for Disease Control and Prevention (CDC), CSAM, and other subject matter experts. 
  • As with any clinical recommendations, provider judgment should govern considerations involved in high quality and evidence-based patient care. 
  • Importantly, these recommendations should not be interpreted to require involuntary and/or rapid tapers, which can be more harmful than they are beneficial by putting patients at risk for poor outcomes such as medical and/or psychiatric decompensation, relapse or illicit drug use, overdose, and self-harm. Tapering decisions must be made based on the individual circumstances of each case, with careful consideration of the risks and benefits. 
  • Prescribers need to be aware of additional local, state, and federal laws and regulations involving opioid prescribing that may supersede these recommendations. 
  • For any prescribing outside of these recommendations, it is highly advised that the reason(s) be documented in the patient’s medical record. 
  • These recommendations do NOT pertain to palliative care, end-of-life (hospice), or active cancer treatment.

CSAM Newsletter Winter 2018 issue

CSAM News Winter 2018

  • President’s Message – CSAM’s Voice for Treatment is Being Heard
  • California Leads U.S. with Highest Number of Addiction Medicine Fellowships
  • Interested in Supporting Harm Reduction Efforts?
  • A Call to Advocacy Editorial – End Discrimination Against Healthcare Providers with Substance Use Disorders
  • MERF Hosts Record-Breaking Number of Scholars and Mentors at CSAM’s Annual Conference
  • Swath of Bills Signed Into Law by Governor Brown
  • CSAM Seeks a Seat in the House of Medicine
  • CSAM Awards Recognize Outstanding Achievement and Service

CSAM Newsletter Spring 2018 issue

CSAM News Spring 2018

  • President’s Message – What’s Ahead for CSAM in 2018?
  • Applying Your Addiction Medicine Know-How
  • CSAM Implements Grant to Expand Medication-Assisted Treatment in California
  • Membership Update – Vote to Include Associate Members Passes
  • CSAM Welcomes a New Education Director